scholarly journals In vitro effects of lactated Ringer's solution, hypertonic saline, hydroxyethyl starch, hypertonic saline/hydroxyethyl starch, and mannitol on thromboelastographic variables of canine whole blood

2020 ◽  
Vol 30 (3) ◽  
pp. 255-263
Author(s):  
Adelina Chan ◽  
Dez Hughes ◽  
Brett S. Tennent‐Brown ◽  
Manuel Boller
2000 ◽  
Vol 90 (2) ◽  
pp. 274-279 ◽  
Author(s):  
Christoph J. Konrad ◽  
Timo J. Markl ◽  
Guido K. Schuepfer ◽  
Joachim Schmeck ◽  
Helmut R. Gerber

2000 ◽  
Vol 90 (2) ◽  
pp. 274 ◽  
Author(s):  
Christoph J. Konrad ◽  
Timo J. Markl ◽  
Guido K. Schuepfer ◽  
Joachim Schmeck ◽  
Helmut R. Gerber

1999 ◽  
Vol 88 (3) ◽  
pp. 483-488 ◽  
Author(s):  
Christoph Konrad ◽  
Timo Markl ◽  
Guido Schuepfer ◽  
Helmut Gerber ◽  
Markus Tschopp

Author(s):  
Alexander A Hanke ◽  
Stephanie Maschler ◽  
Herbert Schöchl ◽  
Felix Flöricke ◽  
Klaus Görlinger ◽  
...  

2007 ◽  
Vol 106 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Carlo A. Volta ◽  
Valentina Alvisi ◽  
Matilde Campi ◽  
Elisabetta Marangoni ◽  
Raffaele Alvisi ◽  
...  

Background Excessive production of matrix metalloproteinase 9 (MMP-9) is linked to tissue damage and anastomotic leakage after large bowel surgery. Hence, the aim of this study was to verify whether different strategies of fluids administration can reduce MMP-9 expression. Methods In the in vitro experiment, the authors tested the hypothesis of a direct inhibition of MMP-9 by the fluids used perioperatively, i.e., lactated Ringer's solution, 3.4% poligeline, and hydroxyethyl starch 130/0.4. In the in vivo experiment, 36 patients undergoing surgery for colon cancer were randomly assigned to three groups to receive lactated Ringer's solution, poligeline, or hydroxyethyl starch. MMP-9 and tissue inhibitor of metalloproteinases were measured from venous blood samples; the MMP-9/tissue inhibitor of metalloproteinases ratio was calculated as an index of equilibrium between the action of MMP-9 and its inhibition. Results In the in vitro experiment, the presence of hydroxyethyl starch 130/0.4 in the MMP-9 assay system showed a strong inhibition of the enzymatic activity compared with lactated Ringer's solution. In the in vivo experiment, MMP-9 and tissue inhibitor of metalloproteinases plasma levels did not differ among the three groups at baseline, whereas those levels increased significantly at the end of surgery. At that time, the MMP-9 plasma levels and the MMP-9/tissue inhibitor of metalloproteinases ratio were significantly higher in the lactated Ringer's solution and poligeline groups than in the hydroxyethyl starch group. These results were confirmed 72 h after surgery. Conclusions This study demonstrates that hydroxyethyl starch 130/04 decreases the circulating levels of MMP-9 in patients undergoing abdominal surgery.


2002 ◽  
Vol 96 (6) ◽  
pp. 1371-1380 ◽  
Author(s):  
Dan Drobin ◽  
Robert G. Hahn

Background Major differences in plasma volume expansion between infusion fluids are fairly well known, but there is a lack of methods that express their dynamic properties. Therefore, a closer description enabled by kinetic modeling is presented. Methods Ten healthy male volunteers received, on different occasions, a constant-rate intravenous infusion over 30 min consisting of 25 ml/kg of 0.9% saline, lactated Ringer's solution, acetated Ringer's solution, 5 ml/kg of 7.5% saline, or 3 ml/kg of 7.5% saline in 6% dextran. One-, two-, and three-volume kinetic models were fitted to the dilution of the total venous hemoglobin concentration over 240 min. Osmotic fluid shifts were considered when hypertonic fluid was infused. Results All fluids induced plasma dilution, which decreased exponentially after the infusions. The ratio of the area under the dilution-time curve and the infused fluid volume showed the following average plasma-dilution dose-effect (efficiency), using 0.9% saline as the reference (= 1): lactated Ringer's solution, 0.88; acetated Ringer's solution, 0.91; hypertonic saline, 3.97; and hypertonic saline in dextran, 7.22 ("area approach"). Another comparison, based on kinetic analysis and simulation, showed that the strength of the respective fluids to dilute the plasma by 20% within 30 min was 0.94, 0.97, 4.44, and 6.15 ("target dilution approach"). Between-subject variability was approximately half as high for the latter approach. Conclusions The relative efficiency of crystalloid infusion fluids differs depending on whether the entire dilution-time profile or only the maximum dilution is compared. Kinetic analysis and simulation is a useful tool for the study of such differences.


Sign in / Sign up

Export Citation Format

Share Document